Stocksigma LogoStocksigma Logo

Accretion Pharmaceuticals Seeks Shareholder Approval for Major Limit Hikes and MOA Alteration

Accretion Pharmaceuticals Limited has issued a Postal Ballot notice seeking shareholder approval for key strategic and financial proposals

Accretion Pharmaceuticals Seeks Shareholder Approval for Major Limit Hikes and MOA Alteration

Accretion Pharmaceuticals Ltd · Annual General Meeting · 10 Sept 2026, 2:01 am

Accretion Pharmaceuticals Seeks Shareholder Approval for Major Limit Hikes and MOA Alteration Accretion Pharmaceuticals Limited has issued a Postal Ballot notice seeking shareholder approval for key strategic and financial proposals. The company proposes altering its MOA Object Clause to support expansion into broader healthcare, diagnostic, and dietary sectors. Additionally, it plans to raise its borrowing limits from ₹100 crore to ₹500 crore over paid-up capital, free reserves, and share premium under Section 180(1)(c). Further proposals include enhancing limits for loans, guarantees, and securities to subsidiaries (Section 185) and inter-corporate investments (Section 186) up to ₹100 crore each. Remote e-voting runs from 10th Sep'26 to 9th Oct'26.

Original exchange filing (PDF)

More announcements from Accretion Pharmaceuticals Ltd

All Accretion Pharmaceuticals Ltd announcements